Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Fox

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Respirology (Carlton, Vic.)|December 13, 2007
Anti-IgE in severe persistent allergic asthmaHoward Fox
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Battle of animal modelsYuri Persidsky, Howard Fox
Journal of Biomedical Research|June 12, 2020
Severer nodular lesion in white matter than in gray matter in simian immunodeficiency virus-infected monkey, but not closely correlated with viral infectionJingdong Zhang, Howard Fox, Huangui Xiong
Journal of Biomedical Research|November 8, 2018
Direct contacts of microglia on myelin sheath and Ranvier's node in the corpus callosum in ratsJingdong Zhang, Xinglong Yang, You Zhou, et al.
Biomed Research International|March 14, 2013
Increased toll-like receptor signaling pathways characterize CD8+ cells in rapidly progressive SIV infectionMaria Cecilia Garibaldi Marcondes, Celsa Spina, Eduardo Bustamante, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 3, 2011
HIV-1 gp120-induced axonal injury detected by accumulation of β-amyloid precursor protein in adult rat corpus callosumJingdong Zhang, Jianuo Liu, Bryan Katafiasz, et al.
Chest|April 14, 2004
Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthmaJean Bousquet, Sally Wenzel, Stephen Holgate, et al.
Current Medical Research and Opinion|November 2, 2006
Improvement in quality of life with omalizumab in patients with severe allergic asthmaBradley Chipps, Roland Buhl, Kai-Michael Beeh, et al.
The Journal of Biological Chemistry|October 10, 2006
Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entryUdayan Chatterji, Michael D Bobardt, Peter Gaskill, et al.
Current Medical Research and Opinion|November 5, 2003
Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthmaGuenther Hochhaus, Laurence Brookman, Howard Fox, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Respirology (Carlton, Vic.)|December 13, 2007
Anti-IgE in severe persistent allergic asthmaHoward Fox
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Battle of animal modelsYuri Persidsky, Howard Fox
Journal of Biomedical Research|June 12, 2020
Severer nodular lesion in white matter than in gray matter in simian immunodeficiency virus-infected monkey, but not closely correlated with viral infectionJingdong Zhang, Howard Fox, Huangui Xiong
Journal of Biomedical Research|November 8, 2018
Direct contacts of microglia on myelin sheath and Ranvier's node in the corpus callosum in ratsJingdong Zhang, Xinglong Yang, You Zhou, et al.
Biomed Research International|March 14, 2013
Increased toll-like receptor signaling pathways characterize CD8+ cells in rapidly progressive SIV infectionMaria Cecilia Garibaldi Marcondes, Celsa Spina, Eduardo Bustamante, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 3, 2011
HIV-1 gp120-induced axonal injury detected by accumulation of β-amyloid precursor protein in adult rat corpus callosumJingdong Zhang, Jianuo Liu, Bryan Katafiasz, et al.
Chest|April 14, 2004
Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthmaJean Bousquet, Sally Wenzel, Stephen Holgate, et al.
Current Medical Research and Opinion|November 2, 2006
Improvement in quality of life with omalizumab in patients with severe allergic asthmaBradley Chipps, Roland Buhl, Kai-Michael Beeh, et al.
The Journal of Biological Chemistry|October 10, 2006
Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entryUdayan Chatterji, Michael D Bobardt, Peter Gaskill, et al.
Current Medical Research and Opinion|November 5, 2003
Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthmaGuenther Hochhaus, Laurence Brookman, Howard Fox, et al.
Pageof 3